Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Factors”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Not applicableUnknownNCT01864395
What this trial is testing

Clinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of MUF

Who this might be right for
Coronary Artery DiseaseAnemia
University of Saskatchewan 90
Not applicableUnknownNCT00456287
What this trial is testing

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome

Who this might be right for
Sleep ApneaCardiovascular Diseases
Sociedad Española de Neumología y Cirugía Torácica 40
Testing effectiveness (Phase 2)UnknownNCT04833764
What this trial is testing

Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

Who this might be right for
Post-thrombotic SyndromeDeep Vein Thrombosis Leg
Khanh Nguyen 30
Not applicableUnknownNCT03273998
What this trial is testing

Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital

Who this might be right for
Coagulation Factor Deficiency
Assiut University 50
Not applicableNot Yet RecruitingNCT06432387
What this trial is testing

Coagulation Factors Alterations in Patients Undergoing Complex Thoraco-abdominal Aortic Aneurysm Repair

Who this might be right for
Thoraco-abdominal Aortic Aneurysm RepairCoagulation Factors AlterationsPlatelet Activation
University of Thessaly 58
Testing effectiveness (Phase 2)Study completedNCT01020006
What this trial is testing

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Who this might be right for
Pancreatic CancerDuctal AdrenocarcinomaExocrine Pancreatic Cancer
Pharmacyclics LLC. 42
Large-scale testing (Phase 3)Study completedNCT04456387
What this trial is testing

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Who this might be right for
Hemophilia A
Zhengzhou Gensciences Inc 119
Not applicableUnknownNCT03914209
What this trial is testing

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia

Who this might be right for
Haemophilia
Investigación en Hemofilia y Fisioterapia 40
Not applicableUnknownNCT02892630
What this trial is testing

Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Assistance Publique - Hôpitaux de Paris 300
Not applicableActive Not RecruitingNCT05643560
What this trial is testing

An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.

Who this might be right for
Hemophilia AProphylaxis of Bleeding
Bayer 33
Large-scale testing (Phase 3)Active Not RecruitingNCT04644575
What this trial is testing

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 261
Early research (Phase 1)Study completedNCT02470871
What this trial is testing

Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency

Who this might be right for
Congenital Coagulation Factor VII Deficiency
CSL Behring 9
Not applicableLooking for participantsNCT06513611
What this trial is testing

Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeStress HyperglycemiaCortisol; Hypersecretion+2 more
Hospital de Clinicas José de San Martín 150
Not applicableStudy completedNCT02134171
What this trial is testing

Early Predictive Factors of Cardiac and Cerebral Involvement in TMA

Who this might be right for
Thrombotic MicroangiopathiesThrombotic Thrombocytopenic Purpura
Assistance Publique - Hôpitaux de Paris 119
Not applicableStudy completedNCT02484534
What this trial is testing

Thrombin Generation Test in Patient With Liver Cirrhosis

Who this might be right for
Cirrhosis
HaEmek Medical Center, Israel 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06399289
What this trial is testing

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Who this might be right for
Hemophilia B
CSL Behring 23
Early research (Phase 1)UnknownNCT04060836
What this trial is testing

Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

Who this might be right for
Hemophilia A
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Not applicableStudy completedNCT03421184
What this trial is testing

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus

Who this might be right for
Lupus ErythematosusRheumatoid ArthritisAutoimmune Thrombocytopenia
University Hospital, Bordeaux 63
Large-scale testing (Phase 3)Study completedNCT05147662
What this trial is testing

Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

Who this might be right for
Treatment of BleedingProphylaxis of BleedingHemophilia A+1 more
Bayer 36
Load More Results